Background {#Sec1}
==========

Several radiological features delineated by chest computed tomography (CT) of non-small cell lung cancer (NSCLC) have been reported to be associated with some utility in detecting the gene mutation status, such as *epidermal growth factor receptor* (*EGFR*) or *anaplastic lymphoma kinase* (*ALK*) rearrangement. Certain features of a tumor on chest CT, such as convergence, notch, and a pleural tail, have been reported to have a significant association with an *EGFR* or *ALK* fusion gene mutation \[[@CR1]--[@CR5]\]. With regard to the mutation of the *ALK* fusion gene, the combination of certain tumor features on chest CT, such as a central tumor location, large pleural effusion, and the absence of a pleural tail, and a younger patient age (\<60 years old), were shown to have a significant relationship with *ALK* rearrangement in patients with NSCLC \[[@CR6]\]. In general, larger squamous cell carcinomas often show cavitation, and cavitary masses have been found in a number of adenocarcinoma patients who had a poor prognosis \[[@CR7]\].

We herein report a case of surgically resected lung adenocarcinoma that presented as a cavitary mass harboring *ALK* fusion with rare radiological features.

Case presentation {#Sec2}
=================

A 68-year-old female was found to have a cavitary mass on annual chest roentgenography in December 2015. She had a history of treatment for cervical cancer in the uterus in 2001 and had been followed up at our hospital without recurrence. She was a never-smoker and had no significant abnormalities on a physical examination except for an abdominal scar related to the treatment for her cervical cancer.

Chest CT revealed a cavitary mass, approximately 4.3 cm in its maximum dimension, in the basal segment of the right lower lobe of the lung (Fig. [1](#Fig1){ref-type="fig"}a). In addition, we noted 2 pure ground-glass-opacity nodules (p-GGNs), 8 and 12 mm in their maximum dimensions. Retrospectively, abdominal CT performed in 2008 occasionally revealed a tiny nodule in the basal segment of the right lower lobe adjacent to the visceral pleura on the diaphragm (Fig. [1](#Fig1){ref-type="fig"}b). No significant hilar or mediastinal lymph node swelling was observed. fluorodeoxyglucose positron emission tomography (FDG-PET) showed no abnormal accumulation except in the mass in the right lower lobe. A biopsy of the tumor via fiber optic bronchoscopy could not distinguish the cavitary mass from a metastatic or primary tumor. The two p-GGNs were considered to be multiple primary lung cancers. The patient underwent video-assisted thoracoscopic right lower lobectomy, partial resections for the two p-GGNs in the right upper lobe, and systemic hilar mediastinal lymph node dissection as curative intent resection. An analysis of the intraoperative frozen sections for the three tumors revealed adenocarcinoma.Fig 1**a** Chest cross-sectional computed tomography (CT) showing a cavitary mass in the S6 segment in the peripheral area with a pleural tail and without pleural effusion. **b** An abdominal CT scan taken in 2008 occasionally showed a tiny nodule on the basal segment of the *right* lower lobe adjacent to the visceral pleura on the diaphragm (*arrow*). **c** The results of a histological examination. Invasive mucinous adenocarcinoma with signet-ring cells in an S6 tumor (hematoxylin and eosin staining, original magnification ×400)

A pathological examination revealed the cavitary mass in the right lower lobe to be invasive mucinous adenocarcinoma (60% acinar, 30% micropapillary, 10% papillary growth pattern) with signet-ring cells (Fig. [1](#Fig1){ref-type="fig"}c). Mediastinal lymph node metastasis was found in the subcarinal lesion. The two p-GGNs were pathologically different from the cavitary mass in the right lower lobe; thus, the pathological diagnosis was multiple primary NSCLC: pT2aN2M0 stage IIIA adenocarcinoma for the cavitary mass in the right lower lobe and pT1aN0M0 stage IA adenocarcinoma for each p-GGN in the right upper lobe. The patient received four cycles of cisplatin and vinorelbine as adjuvant chemotherapy. In addition, *ALK* rearrangement was detected by FISH from the specimen obtained from the cavitary mass on the right lower lobe. The postoperative course was uneventful, and the patient is currently disease-free at 5 months post operation.

Discussion {#Sec3}
----------

Previous reports have shown that some CT features are significantly associated with the *ALK* fusion gene \[[@CR2]--[@CR5]\]. Yamamoto et al. reported that three CT features, namely a central tumor location, large pleural effusion, and the absence of pleural tail, with a patient age of less than 60 years, were good predictors of the presence of the *ALK* fusion gene in cases of NSCLC \[[@CR6]\]. In addition, Yamamoto et al. attempted to predict the presence of the *ALK* fusion gene using those three CT features and the age of patients and revealed a sensitivity and specificity of 89.4 and 100.0%, respectively, for the presence of the *ALK* fusion gene in certain cohorts of patients. However, the equation failed to demonstrate the presence of the *ALK* fusion gene in our patient in the present report. Retrospectively, a tiny nodule was occasionally found in the basal segment adjacent to the visceral pleura (the peripheral area of the right lung on an abdominal CT taken 8 years prior as a follow-up of cervical cancer of the uterus; Fig. [1](#Fig1){ref-type="fig"}b). The present case therefore differed with respect to the predictive factors for the presence of the *ALK* gene fusion in the cavity formation in the tumor, an initial tumor location in a peripheral site without pleural tail formation, and a patient age over 60 years old.

With regard to the pathological features of this case, the permanent specimen showed invasive mucinous adenocarcinoma with signet-ring cells (Fig. [1](#Fig1){ref-type="fig"}c). Signet-ring cells are a rare feature of primary lung adenocarcinoma \[[@CR7]\]; the presence of signet-ring-cell elements is significantly more frequent in *ALK*+ lung cancer \[[@CR8]\]. Given that the *ALK* status of the patient was positive, these findings were consistent with those of previous reports.

Conclusions {#Sec4}
===========

We report a case of NSCLC harboring *ALK* rearrangement with uncommon radiological features. The *ALK* gene status of NSCLC with atypical CT features should also be investigated.
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